Patents by Inventor James Lanter

James Lanter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080119522
    Abstract: The present invention is directed to novel benzimidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.
    Type: Application
    Filed: January 25, 2008
    Publication date: May 22, 2008
    Inventors: Raymond Ng, Zhihua Sui, Jihua Guan, James Lanter, Vernon Alford
  • Publication number: 20080070970
    Abstract: The present invention is directed to novel indole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.
    Type: Application
    Filed: September 20, 2007
    Publication date: March 20, 2008
    Inventors: James Lanter, Zhihua Sui, James Fiordeliso, Weiqin Jiang, Xuqing Zhang
  • Publication number: 20070208014
    Abstract: The present invention is directed to a novel 2-substituted benzimidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.
    Type: Application
    Filed: January 23, 2007
    Publication date: September 6, 2007
    Inventors: Vernon Alford, James Lanter, Raymond Ng
  • Patent number: 7087628
    Abstract: This invention relates to a series of N-heterocyclyl hydrazides of Formula I, and pharmaceutical compositions containing them. The compounds of the invention have neurotrophic activity and are useful in the treatment and prevention of neuronal disorders such as Parkinson's disease, Alzheimer's disease, stroke, multiple sclerosis, amyotrophic lateral sclerosis diabetic neuropathy and Bell's palsy.
    Type: Grant
    Filed: October 4, 2002
    Date of Patent: August 8, 2006
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: Zhihua Sui, Mark Macielag, James Lanter
  • Publication number: 20060116412
    Abstract: The present invention is directed to novel benzimidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.
    Type: Application
    Filed: September 26, 2005
    Publication date: June 1, 2006
    Inventors: Raymond Ng, Zhihua Sui, Jihua Guan, James Lanter, Vernon Alford
  • Publication number: 20060111402
    Abstract: The present invention is directed to novel benzimidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.
    Type: Application
    Filed: September 26, 2005
    Publication date: May 25, 2006
    Inventors: Raymond Ng, Zhihua Sui, Jihua Guan, James Lanter, Vernon Alford
  • Publication number: 20060063819
    Abstract: The present invention is directed to novel imidazolidin-2-one derivatives having a structure according to Formula I wherein a, b, R1, R2, R3, and R4 are as defined above, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.
    Type: Application
    Filed: September 9, 2005
    Publication date: March 23, 2006
    Inventors: James Lanter, Zhihua Sui
  • Publication number: 20060040917
    Abstract: The present invention is directed to novel benzoxazepine derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and diseases mediated by an estrogen receptor.
    Type: Application
    Filed: July 28, 2005
    Publication date: February 23, 2006
    Inventors: James Lanter, Zhihua Sui, James Fiordeliso
  • Publication number: 20050250741
    Abstract: The present invention is directed to novel indole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.
    Type: Application
    Filed: April 1, 2005
    Publication date: November 10, 2005
    Inventors: James Lanter, Zhihua Sui, James Fiordeliso, Weiqin Jiang, Xuqing Zhang
  • Publication number: 20050250740
    Abstract: The present invention is directed to novel indole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.
    Type: Application
    Filed: April 1, 2005
    Publication date: November 10, 2005
    Inventors: James Lanter, Zhihua Sui, James Fiordeliso, Weiqin Jiang, Xuqing Zhang
  • Publication number: 20050245485
    Abstract: The present invention is directed to novel indole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.
    Type: Application
    Filed: April 1, 2005
    Publication date: November 3, 2005
    Inventors: James Lanter, Zhihua Sui, James Fiordeliso, Weiqin Jiang, Xuqing Zhang
  • Publication number: 20050113402
    Abstract: The invention relates to novel pyrrolopyridinone derivatives of the formula (I) or (II): pharmaceutical compositions containing the compounds and their use for the treatment of sexual dysfunction.
    Type: Application
    Filed: October 22, 2004
    Publication date: May 26, 2005
    Inventors: Zhihua Sui, Mark Macielag, Jihua Guan, Weigin Jiang, James Lanter
  • Publication number: 20050107372
    Abstract: The present invention is directed to novel 2-(quinolonyl)-fused heterocyclyl derivatives of the general formula (I) wherein R1, R2, R3, R3a, R4, R5, R6 and R7 are as herein defined, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.
    Type: Application
    Filed: September 29, 2004
    Publication date: May 19, 2005
    Inventors: James Lanter, Zhihua Sui, James Fiordeliso
  • Publication number: 20030144262
    Abstract: This invention relates to a series of N-heterocyclyl hydrazides of Formula I, 1
    Type: Application
    Filed: October 4, 2002
    Publication date: July 31, 2003
    Inventors: Zhihua Sui, Mark Macielag, James Lanter